Fundz

Rezo Therapeutics Appoints Derek Hicks as Chief Executive Officer

PRIVATEAug 12, 2025

Position

Chief Executive Officer

Company

Rezo Therapeutics

Derek Hicks
derek.hicks@rezotx.com
San FranciscoBiotechnologyHealth CareArtificial IntelligenceGeneticsresearch

Description

Rezo Therapeutics announced the appointment of Derek Hicks as CEO, effective August 12, 2025. With over 25 years of experience in the pharmaceutical and biotech sectors, Derek is expected to lead the company in redefining treatments for cancer and other complex diseases.

Quick answer

Rezo Therapeutics Appoints Derek Hicks as Chief Executive Officer (August 12, 2025). Rezo Therapeutics is based in San Francisco, California, United States.

Who is the new Chief Executive Officer at Rezo Therapeutics?
Rezo Therapeutics named Derek Hicks Chief Executive Officer, announced August 12, 2025.
What did Rezo Therapeutics announce on August 12, 2025?
Rezo Therapeutics announced the appointment of Derek Hicks as CEO, effective August 12, 2025. With over 25 years of experience in the pharmaceutical and biotech sectors, Derek is expected to lead the company in redefining treatments for cancer and other complex diseases.
What does Rezo Therapeutics do?
Rezo is a different kind of biopharma company.
Where is Rezo Therapeutics based?
Rezo Therapeutics is based in San Francisco, California, United States.
Which similar companies made leadership changes around the same time?
Applied StemCell (August 21, 2025), Legend Biotech (August 18, 2025), Geron (August 6, 2025) and Cantargia AB (August 18, 2025) also announced leadership changes within 45 days of Rezo Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Genetics and research

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Rezo Therapeutics, and when

A new leader at Rezo Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Rezo Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Rezo Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Rezo Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Rezo Therapeutics

Location

455 Mission Bay Blvd S

San Francisco, California, United States

About

Rezo is a different kind of biopharma company. Our mission is to dramatically increase the success rate of drug development by building a disease-agnostic, fully-integrated, network biology platform that will redefine our understanding of human disease and ability to treat it. Our Founders and members of the Board are a group of esteemed, world-class scientists from the University of California, San Francisco: Nevan Krogan, Kevan Shokat, Sourav Bandyopadhyay, Natalia Jura, as well as renowned biotech executives George Scangos and Norbert Bischofberger. These leaders bring with them a strong track record of amazing discoveries and scientific breakthroughs, leading to very successful companies and many FDA approved drugs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Rezo Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Nadir
Likely contact at this company
••••••••@••••••••

See Nadir's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Rezo Therapeutics's next move

Learn about Strategic plan

Rezo Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.